Wealth Enhancement Advisory Services LLC Buys 4,039 Shares of UiPath Inc. (NYSE:PATH)

Wealth Enhancement Advisory Services LLC boosted its stake in shares of UiPath Inc. (NYSE:PATH) by 15.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 30,479 shares of the healthcare company’s stock after buying an additional 4,039 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in UiPath were worth $691,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of PATH. Royal London Asset Management Ltd. increased its position in shares of UiPath by 5.9% during the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company’s stock valued at $2,388,000 after purchasing an additional 7,742 shares during the period. Wellington Management Group LLP increased its holdings in UiPath by 59.0% in the 3rd quarter. Wellington Management Group LLP now owns 99,930 shares of the healthcare company’s stock valued at $1,710,000 after buying an additional 37,062 shares during the period. Vanguard Group Inc. raised its stake in shares of UiPath by 7.6% in the 3rd quarter. Vanguard Group Inc. now owns 37,750,773 shares of the healthcare company’s stock valued at $645,916,000 after buying an additional 2,673,718 shares in the last quarter. Symmetry Partners LLC acquired a new stake in shares of UiPath during the 4th quarter valued at about $205,000. Finally, Green Alpha Advisors LLC bought a new stake in UiPath in the fourth quarter valued at about $772,000. 62.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PATH has been the topic of a number of analyst reports. Barclays upped their price target on UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research report on Friday, September 6th. DA Davidson boosted their price target on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Evercore ISI lifted their target price on shares of UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research note on Friday, September 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $16.00 price target on shares of UiPath in a report on Friday, September 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research note on Wednesday, October 23rd. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.47.

UiPath Stock Performance

Shares of PATH stock traded up $0.02 during trading hours on Tuesday, reaching $12.34. The company had a trading volume of 1,202,705 shares, compared to its average volume of 9,513,894. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87. The company has a 50 day moving average of $12.53 and a 200 day moving average of $13.73.

UiPath (NYSE:PATH) last issued its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to analysts’ expectations of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.09) earnings per share. Equities research analysts forecast that UiPath Inc. will post -0.23 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 22.37% of the company’s stock.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.